Status:
COMPLETED
Therapeutic Induction of Endogenous Antibiotics
Lead Sponsor:
International Centre for Diarrhoeal Disease Research, Bangladesh
Collaborating Sponsors:
Swedish International Development Cooperation Agency (SIDA)
Karolinska Institutet
Conditions:
Shigellosis
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
Shigellosis is one of the major causes of morbidity and mortality in many developing countries. The continued emergence of antibiotic resistant strains has complicated the treatment of shigellosis and...
Detailed Description
Study design: A double blind randomized clinical trial with subsequent follow-up. Study Subjects: Adult male and female patients attending the Clinical Research and Service Center (CRSC) of ICDDR,B a...
Eligibility Criteria
Inclusion
- 18-55 years of age
- duration of diarrhoea 0-4 days
- culture-confirmed Shigella spp (all Shigella spp) in stool on enrolment
Exclusion
- who received antimicrobial treatment before attending the ICDDR,B hospital
- clinical symptoms of other concomitant infections (such as chronic respiratory infections, other concomitant gastrointestinal infections)
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00800930
Start Date
January 1 2005
End Date
January 1 2009
Last Update
December 8 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dhaka Hospital & Matlab Hospital
Dhaka, Bangladesh, 1212
2
ICDDR,B
Dhaka, Bangladesh, 1212